Lilly, NIAID & Care Access Research Transform How Studies Done to Reach Nursing Homes During COVID-19 Pandemic

Lilly, NIAID & Care Access Research Transform How Studies Done to Reach Nursing Homes During COVID-19 Pandemic

On Aug. 3, TrialSite applauded the effort of  Lilly & Co. (NYSE: LLY) and the National Institute of Allergy and Infectious Diseases (NIAID) for the Blaze-2 clinical trial. Why? Because it’s one of the first, if not the first nationwide intervention during the COVID-19 pandemic to help save elderly residents in long-term care facilities (LTC). The residents at these facilities have experienced horrific and unacceptable death rates. In this pivotal Phase 3 clinical trial, Lilly and partner NIAID mobilize a fleet of customized mobile units to support LTC facilities around the nation to treat elderly with the very promising monoclonal antibody product LY-CoV555 (again developed thanks to a partnership with AbCellera, NIAID and dedicated Lilly scientists). Care Access Research, a partner in this critically important endeavor, recently shared some updates on this study and its importance to the elderly, long term care facilities during the pandemic. 

Recently updated by Alex Spanko writing for Skilled Nursing News, Lilly has helped transform the paradigm of how to reach the elderly in a pandemic. Traditional research procedures wouldn’t allow for the elderly to participate in suc...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee